Work

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

Year: 2012

Type: article

Study design: Clinical Trial

Source: International Clinical Psychopharmacology

DOI: 10.1097/yic.0b013e32835b0814

Authors: Guy M. Goodwin, Patrice Boyer, Robin Emsley, Frédéric Rouillon, Christian de Bodinat

Institutions: Warneford Hospital, University of Oxford, University of Ottawa, Université Paris Diderot, Stellenbosch University, Ste. Anne's Hospital, Institut de Recherches Internationales Servier (France)

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Sanofi, Servier

OpenAlex ID: W2055658079

FWCI: 1.293

Cites:

Cited by: 20

Related to: 10